LIFECORE BIOMEDICAL, INC. DE (LFCR) › Weighted Average Diluted SharesLIFECORE BIOMEDICAL, INC. DE (LFCR) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2010-05-30: 26.6K2011-05-29: 26.63M2012-05-27: 26.13M2013-05-26: 26.6K2014-05-25: 27.12M2015-05-31: 27.34M2016-05-29: 27.04M2017-05-28: 27.65M2018-05-27: 27.91M2019-05-26: 28.61M2020-05-31: 29.16M2021-05-30: 29.29M2022-05-29: 29.47M2023-05-28: 29.96M2024-05-26: 36.66M2025-05-25: 34.82M34.82M2010-05-30Weighted Average Diluted Shares (shares)2025-05-25Period endedWeighted Average Diluted SharesChange YoYSource filing2025-05-2534.82M-5.0%2025-08-07From 2024-05-272024-05-2636.66M+22.4%2025-08-07From 2023-05-292023-05-2829.96M+1.7%2024-08-26From 2022-05-302022-05-2929.47M+0.6%2024-08-26From 2021-05-312021-05-3029.29M+0.5%2024-03-20From 2020-06-012020-05-3129.16M+1.9%2023-03-16From 2019-05-272019-05-2628.61M+2.5%2021-07-29From 2018-05-282018-05-2727.91M+1.0%2020-08-14From 2017-05-292017-05-2827.65M+2.2%2019-08-01From 2016-05-302016-05-2927.04M-1.1%2018-08-09From 2015-06-012015-05-3127.34M+0.8%2018-03-15From 2014-05-262014-05-2527.12M+101755.3%2016-08-01From 2013-05-272013-05-2626.6K-99.9%2015-07-31From 2012-05-282012-05-2726.13M-1.9%2014-08-01From 2011-05-302011-05-2926.63M+99873.7%2013-08-07From 2010-05-312010-05-3026.6K—2012-08-08From 2009-06-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)